Innovent Biologics, Pfizer strike $10.5b partnership deal amid China biotech boom

Innovent Biologics, Pfizer strike $10.5b partnership deal amid China biotech boom

The Pfizer logo is pictured at their building in the Manhattan borough of New York October 29, 2015. REUTERS/Carlo Allegri

29 May, 2026

Innovent Biologics Pfizer

Printed by Unregistered user on Thu, 23 Jul 2026 03:22:47 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Japan's Shionogi hikes stake in ViiV Healthcare in $2.13b deal, Pfizer exits

Pfizer in early talks to buy Seagen for likely for more than $30b

Read more from Greater China

Venture Capital

Consumer-focused BA Capital closes second USD fund at $225m

Climate Tech & ESG

China’s new solar installations fall 66% in H1 as pricing reform rush unwinds